Similar articles

• [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].

  Pescaru C, Tudorache V, Oancea C. Pescaru C, et al. Pneumologia. 2010 Jan-Mar;59(1):27-30. Pneumologia. 2010. PMID: 20432790 Review. Romanian.
• Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

  Le Jemtel TH, Padeletti M, Jelic S. Le Jemtel TH, et al. J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. doi: 10.1016/j.jacc.2006.08.046. Epub 2006 Dec 29. J Am Coll Cardiol. 2007. PMID: 17222727 Review.
• Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?

  Sontheimer D, Hitchcock K, Saseen J. Sontheimer D, et al. J Fam Pract. 2007 Apr;56(4):312-4. J Fam Pract. 2007. PMID: 17403332 Review. No abstract available.
• Comorbidities of chronic obstructive pulmonary disease.

  Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Corsonello A, et al. Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S21-8. doi: 10.1097/01.mcp.0000410744.75216.d0. Curr Opin Pulm Med. 2011. PMID: 22209926 Review.
• COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.

  Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. Decramer M, et al. COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531. COPD. 2008. PMID: 18671149 Review.